Supplement industry experts gather to educate Congress on related issues
NEW YORK It is critical that the dietary supplement industry extol the benefit and value associated with supplementing for health and wellness, especially as today’s legislators determine what health care will look like tomorrow, and how patients will be incentivized into being more proactive around the pursuit of preventative health behaviors.
But just as important in today’s regulatory climate is defending the supplement industry as a predominantly responsible industry providing products based on sound science; and an industry that does not include companies that do not resort to the scare tactic du jour, like marketing a supplement “remedy” for the novel H1N1 virus, for example. Indeed, as the Food and Drug Administration steps up its efforts in publicly outing renegade companies purporting to field supplemental cancer “cures,” or that market products containing undeclared prescription drugs as supplements, only fuels the cry of supplement critics for greater legislation, including the need for pre-market approval.
The Council for Responsible Nutrition and the Natural Products Association have helped organize this quarterly mechanism to do just that — educate Congress leaders — through the Congressional Dietary Supplement Caucus. In addition to Polis, Congressional co-chairs of the caucus include Reps. Dan Burton, R-Ind., Jason Chaffetz, R-Utah, and Robert Wexler, D-Fla.
That’s not all the industry’s done in the past few years to help clean up its image. For example, the industry’s long-awaited supplement-specific good manufacturing practices have been adopted and will be implemented in totality by this time next year, a measure that ought to ensure ingredient integrity. The industry’s support for the inclusion of dietary supplements in serious adverse event reporting positioned the industry not only as a responsible player in a health-focused arena, but should also serve to underscore the underlying safety of supplements. And the industry’s sponsoring of a third-party review of supplement advertising highlights the use of sound science to support many supplement structure/function claims.
Health Enterprises awarded APMA Seal of Acceptance for two products
NORTH ATTLEBORO, Mass. Health Enterprises has been awarded the American Podiatric Medical Association Seal of Acceptance for its Therapeutic Foot Massager and Tru-Ice Reusable Ice Therapy, the company announced Wednesday.
The APMA Seal of Acceptance Program was created to inform podiatric physicians and consumers about products whose quality, safety and effectiveness promote good foot health. In order to qualify for the Seal, products must pass a scientific evaluation by a panel of APMA members and testing at a recognized laboratory.
The Therapeutic Foot Massager helps relieve pain, reduce stress and relax tired feet with three easy-to-use massage options (massage with heat, massage with cold or basic massage). Tru-Ice provides cold therapy to help reduce swelling and relieve pain with an ergonomic, reusable design and patented liner system.
“Both the Therapeutic Foot Massager and Tru-Ice products have been medically proven to bring relief to individuals suffering from foot pain, using the latest technology in over-the-counter foot massage and cold therapy treatments,” stated Ronald Jensen, APMA president.
AAHP responds to report that questions safety of homeopathic remedies
SANTA ROSA, Calif. The American Association of Homeopathic Pharmacists on Friday struck back against an Associated Press report published Thursday that questioned the overall safety of homeopathic remedies in the wake of the warning letter issued by the Food and Drug Administration to Matrixx Initiatives earlier in the week around safety concerns of two Zicam products.
“Consumers and healthcare professionals alike should be assured that the FDA’s action in regard to certain Zicam products does not apply to this class of drugs as a whole,” the association stated. “Rather, the FDA’s advisory relates only to the nasal application of a specific zinc product.”
Homeopathic medications are regulated by the FDA and have been used safely in the United States since before the passage of the 1938 federal Food, Drug and Cosmetic Act, the AAHP added. “The FDA’s Compliance Policy Guide … has been an effective and workable way to regulate homeopathic drugs since 1988, and, as shown by the FDA’s action on June 16, it allows the FDA to take action when action is required to protect the public,” the AAHP stated.